MetaCap

Chemed (CHE) vs U.S. Physical Therapy (USPH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

U.S. Physical Therapy (USPH) has outperformed Chemed (CHE) over the past year, gaining 33.9% versus a gain of 24.2%. Over five years, CHE leads with a +13.5% price change compared with +8.3% for USPH. Chemed is the larger company by market cap ($7.11 billion vs $1.43 billion), about 5.0 times the size, while U.S. Physical Therapy is growing revenue faster (+16.3% vs +4.1%).

On valuation, Chemed trades at a lower forward P/E (19.7x vs 28.5x for U.S. Physical Therapy). U.S. Physical Therapy offers the higher dividend yield (1.91% vs 0.46%). Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 5.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CHE+24.19%USPH+33.92%
+43%+11%-21%
Nov 21, 20251 yearNov 20, 2026
CHE+8.79%USPH+5.32%
+46%+4%-39%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CHE versus USPH key metrics
MetricCHEUSPH
Share price$548.59$95.93
Market cap$7.11B$1.43B
1-day change-0.50%+1.71%
YTD return+28.22%+22.85%
1-year return+24.19%+33.92%
5-year return+13.50%+8.32%
P/E ratio (TTM)26.27—
Forward P/E19.7028.50
EPS (TTM)$20.88$-1.33
Dividend yield0.46%1.91%
Annual dividend$2.50$1.83
Revenue (latest FY)$2.53B$780.99M
Revenue growth (YoY)+4.06%+16.33%
Net income (latest FY)$265.24M$39.58M
Gross margin32.54%19.17%
Operating margin13.37%11.10%
Net margin10.48%5.07%
52-week high$562.24$101.80
52-week low$365.21$58.19
Distance from 52-week high-2.43%-5.77%
Analyst consensusbuybuy
Avg. price target upside+12.47%+16.23%
Average volume154.97K186.22K
Shares outstanding12.96M14.93M
Employees15,8114,653
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Chemed is about 5.0 times larger than U.S. Physical Therapy by market value ($7.11B vs $1.43B).
  • U.S. Physical Therapy offers a meaningfully higher dividend yield (1.91% vs 0.46%).
  • Chemed is more profitable, keeping 10.5 cents of every revenue dollar as net income versus 5.1 cents for U.S. Physical Therapy.
  • U.S. Physical Therapy grew revenue faster in its latest fiscal year (+16.33% vs +4.06%).

About Chemed

CHE stock →

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.

Health Care · Medical/Nursing Services · 15,811 employees

About U.S. Physical Therapy

USPH stock →

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics.

Health Care · Medical/Nursing Services · 4,653 employees

CHE vs USPH FAQ

Which is bigger, Chemed or U.S. Physical Therapy?

Chemed (CHE) is larger, with a market capitalization of $7.11B compared with $1.43B for U.S. Physical Therapy (USPH).

Which stock has performed better over the past year, CHE or USPH?

USPH returned +33.92% over the past 12 months, compared with +24.19% for CHE (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Chemed or U.S. Physical Therapy?

U.S. Physical Therapy has the higher yield at 1.91%, compared with 0.46% for Chemed.

Are Chemed and U.S. Physical Therapy in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons